Table 1.
Patient demographics
| Characteristics | N = 10 |
| Mean (range) age, years | 57.9 ± 9.6 (43–74) |
| Performance status*, n (%) | |
| 80% | 4 (40) |
| 90% | 3 (30) |
| 100% | 3 (30) |
| Sex, n (%) | |
| Male | 7 (70) |
| Female | 3 (30) |
| Race, n (%) | |
| Caucasian | 9 (90) |
| Blacks/Asians | 1 (10) |
| Prior therapy, n (%) | |
| Chemotherapy | |
| 1 prior regimen | 4 (40) |
| ≥2 prior regimens | 6 (60) |
| Radiotherapy | 5 (50) |
| Immunotherapy | 0 (0) |
| Other | 1 (10) |
| HLA-A2†, n (%) | |
| Positive | 3 (30) |
| Negative | 7 (70) |
Abbreviation: †HLA-A2, human leukocyte antigen-A2; * Karnofsky Performance Status (KPS)